J Eur Acad Dermatol Venereol. 2018 Nov 19 [Epub ahead of print]...
Leggi tuttoSi chiede che AIFA riconsideri il Piano Terapeutico per il medicinale Omalizumab...
Leggi tuttoTwo separate clinical studies published in the Journal of Allergy and Clinical Immunology have shown omalizumab to be highly effective against different types of urticaria...
Leggi tuttoThe monoclonal antibody omalizumab appears to reduce episodes of angio-oedema in patients diagnosed with chronic idiopathic urticaria / spontaneous urticaria...
Leggi tuttoPatients with chronic idiopathic/spontaneous urticaria (CIU/CSU) achieve improvements in sleep when treated with the humanised anti-immunoglobulin E (IgE) monoclonal antibody omalizumab...
Leggi tutto